Mononitrates pp 245-253 | Cite as

Double-Blind-Comparison of the Effects of Nifedipine and Isosorbide-5-mononitrate on the Circulatory Response to Exercise, Exercise Tolerance, and ST-Segment Depression in Patients with Ischemic Heart Disease

  • G. Koch
  • L. Fransson
  • L. Karlegärd
  • W. Sauer
  • H. J. Überbacher
Conference paper
Part of the International Boehringer Mannheim Symposia book series (BOEHRINGER)

Abstract

The hemodynamic profiles of calcium antogonists and nitrates are different. Calcium antagonists and, in particular, nifedipine reduce systemic vascular resistance and blood pressure and tend to raise pulse rate and cardiac output. However, even preload, in terms of left ventricular filling pressures, is lowered [4–7], apparently due to a consequent blood volume shift from the intrathoracic to the extrathoracic compartments of the low pressure system. Nitrates do not consistently lower systemic vascular restistance, but they reduce right and left ventricular filling pressures substantially and tend to lower cardiac output by this mechanism [3]. Nitrates have been used for the treatment of angina for more than 100 years and are still one of the most widely used drugs in the management of ischemic heart disease. Calcium antagonists have been increasingly used since their introduction in clinical cardiology some 10 years ago.

Keywords

Placebo Fatigue Depression Ischemia Noradrenaline 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Anonymous (1984) Editorial: Nitrates and angina. Lancet 1:998Google Scholar
  2. 2.
    Ekelund L-G, Orö L (1976) Antianginal efficiency of Adalat with and without a beta-blocker. A subacute study with exercise tests. In: Jatene AD, Lichtlen PR (eds) 3rd International Adalat symposium: new therapy of ischemic heart disease. Excerpta Medica, Amsterdam, pp 218–225Google Scholar
  3. 3.
    Kasparian H, Wiener L, Duca PR, Gottlieb RS, Brest AN (1975) Comparative hemodynamic effects of placebo and oral isosorbide dinitrate in patients with significant coronary artery disease. Am Heart J 90:68–74PubMedCrossRefGoogle Scholar
  4. 4.
    Koch G (1976) Acute hemodynamic effects of nifedipine (Adalat) at rest and during exercise in patients with ischemic heart disease. In: 7th European congress of cardiology, abstracts book II, p26Google Scholar
  5. 5.
    Koch G (1980) Beta-receptor and calcium blockade in ischemic heart disease: effects on systemic and pulmonary hemodynamics and on plasma catecholamines at rest and during exercise. In: Puech P, Krebs R (eds) 4th International Adalat Symposium: New Therapy of Ischemic Heart Disease. Excerpta Medica, Amsterdam, p 131Google Scholar
  6. 6.
    Koch G (1984) Beta-adrenoceptor blockers, calcium antagonists and combined alpha-beta-receptor blockade in coronary heart disease: hemodynamic profiles. In: Rietbrock N, Woodcock BG (eds) Balanced alpha-beta-blockade of adrenoceptors. Vieweg, Wiesbaden (Methods in clinical pharmacology, vol 5), p 171Google Scholar
  7. 7.
    Lydtin H, Schiert W, Lohmüller G (1980) Exercise pulmonary wedge pressure after acute and chronic administration of nifedipine in ischemic heart disease. In: Puech P, Krebs R (eds) 4th International Adalat Symposium: New Therapy of Ischemic Heart Disease. Excerpta Medica, Amsterdam, p 249Google Scholar
  8. 8.
    McCornack RL (1965) Extended tables of the Wilcoxon matched pairs signed rank statistic. J Am Stat Assoc 60:864–871CrossRefGoogle Scholar
  9. 9.
    McNemar Q (1947) Notes on sampling error of the differences between correlation proportions or percentages. Psychometrica 12:153–154CrossRefGoogle Scholar
  10. 10.
    Snedecor GW (1967) Statistical methods, 6th edn. Iowa State University Press, AmesGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  • G. Koch
  • L. Fransson
  • L. Karlegärd
  • W. Sauer
  • H. J. Überbacher

There are no affiliations available

Personalised recommendations